Literature DB >> 11402752

[Role of lymphadenectomy in the surgery of gynecologic cancer].

H B Salvesen1.   

Abstract

BACKGROUND: Complete surgical removal of cancer tissue is a goal in modern cancer treatment, and this is one of the arguments for total lymphadenectomy in gynaecologic cancer surgery.
MATERIAL AND METHODS: Review of the literature identified through limited searches on Medline, Cochrane, Bibsys and the Internet.
RESULTS: Lymphadenectomy improves the staging and represent advanced surgical treatment with considerable complication rates, related to the surgeon's experience. It is likely that lymphadenectomy directly influences survival for vulva and cervical cancer. The effect on survival among endometrial and ovarian cancer patients is unsettled, but prospective randomized trials are ongoing.
INTERPRETATION: Correct staging is especially important in randomized trials of treatment alternatives, and it is the basis for individualised treatment. However, the effect of available treatment is not always well documented, hence the mortality and complication rates related to the procedure should be considered in relation to the potential benefit from the relevant treatment in each patient. Special training in the surgical technique is necessary. For rare conditions, this implies centralization. There are promising new approaches like the sentinel node and laparoscopic techniques, and studies of prognostic tumour markers, that may partially replace total lymphadenectomy in the future.

Entities:  

Mesh:

Year:  2001        PMID: 11402752

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

Review 1.  Lymphadenectomy for the management of endometrial cancer.

Authors:  Katie May; Andrew Bryant; Heather O Dickinson; Sean Kehoe; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 2.  Lymphadenectomy for the management of endometrial cancer.

Authors:  Jonathan A Frost; Katie E Webster; Andrew Bryant; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2017-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.